Jiangsu Recbio Technology's (HKG:2179) board approved the proposed conversion of 141,953,490 unlisted shares into H shares, a Wednesday Hong Kong bourse filing said.
Conversion will take place after the company obtains all necessary approvals.
Following completion, the company will have a total of 458,092,179 H shares in issue, making up 94.85% of its total share capital.
The firm will apply to the Hong Kong Stock Exchange to list and deal in the converted H shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.